Endurant Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-83,217	Closed	-$1.54M	–	75
2022 Q1	$1.54M	Buy	83,217 +15,767	+23%	+$292K	0.41%	43
2021 Q4	$1.33M	Buy	+67,450	New	+$1.33M	0.32%	48